Herrington DM - Search Results

1

Cardiovascular trials of estrogen replacement therapy.

Herrington DM, Klein KP. Herrington DM, et al. Ann N Y Acad Sci. 2001 Dec;949:153-62. doi: 10.1111/j.1749-6632.2001.tb04014.x. Ann N Y Acad Sci. 2001. PMID: 11795347 Review.

2

Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy.

Herrington DM, Braden GA, Williams JK, Morgan TM. Herrington DM, et al. Am J Cardiol. 1994 May 15;73(13):951-2. doi: 10.1016/0002-9149(94)90136-8. Am J Cardiol. 1994. PMID: 8184850 No abstract available.

3

Dehydroepiandrosterone and coronary atherosclerosis.

Herrington DM. Herrington DM. Ann N Y Acad Sci. 1995 Dec 29;774:271-80. doi: 10.1111/j.1749-6632.1995.tb17387.x-i1. Ann N Y Acad Sci. 1995. PMID: 8597465

4

Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).

Herrington DM, Fong J, Sempos CT, Black DM, Schrott HG, Rautaharju P, Bachorik PS, Blumenthal R, Khan S, Wenger NK. Herrington DM, et al. Am Heart J. 1998 Jul;136(1):115-24. doi: 10.1016/s0002-8703(98)70191-7. Am Heart J. 1998. PMID: 9665228 Clinical Trial.

5

Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.

Dubuisson JT, Wagenknecht LE, D'Agostino RB Jr, Haffner SM, Rewers M, Saad MF, Laws A, Herrington DM. Dubuisson JT, et al. Among authors: herrington dm. Diabetes Care. 1998 Nov;21(11):1790-6. doi: 10.2337/diacare.21.11.1790. Diabetes Care. 1998. PMID: 9802722

6

Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.

Herrington DM, Werbel BL, Riley WA, Pusser BE, Morgan TM. Herrington DM, et al. J Am Coll Cardiol. 1999 Jun;33(7):2030-7. doi: 10.1016/s0735-1097(99)00128-x. J Am Coll Cardiol. 1999. PMID: 10362210 Free article. Clinical Trial.

7

The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study.

Herrington DM. Herrington DM. Ann Intern Med. 1999 Sep 21;131(6):463-6. doi: 10.7326/0003-4819-131-6-199909210-00012. Ann Intern Med. 1999. PMID: 10498564

8

The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?

Wells G, Herrington DM. Wells G, et al. Among authors: herrington dm. Drugs Aging. 1999 Dec;15(6):419-22. doi: 10.2165/00002512-199915060-00001. Drugs Aging. 1999. PMID: 10641952 Review.

9

The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.

Herrington DM, Reboussin DM, Klein KP, Sharp PC, Shumaker SA, Snyder TE, Geisinger KR. Herrington DM, et al. Control Clin Trials. 2000 Jun;21(3):257-85. doi: 10.1016/s0197-2456(00)00054-4. Control Clin Trials. 2000. PMID: 10822123 Clinical Trial.

10

Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.

Herrington DM, Pusser BE, Riley WA, Thuren TY, Brosnihan KB, Brinton EA, MacLean DB. Herrington DM, et al. Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1606-12. doi: 10.1161/01.atv.20.6.1606. Arterioscler Thromb Vasc Biol. 2000. PMID: 10845879 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters